Clinical Trials Directory

Trials / Completed

CompletedNCT01030159

National Cancer Institute Thai Cancer Anemia Survey

Anemia Survey in Cancer Patients Study

Status
Completed
Phase
Study type
Observational
Enrollment
300 (actual)
Sponsor
Janssen-Cilag Ltd.,Thailand · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.

Detailed description

Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemaglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered

Conditions

Interventions

TypeNameDescription
OTHERAdult Cancer PatientsTracking anemia management in Adult Cancer Patients

Timeline

Start date
2006-06-01
Primary completion
2008-05-01
Completion
2008-05-01
First posted
2009-12-11
Last updated
2014-04-09

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01030159. Inclusion in this directory is not an endorsement.